Damanskienė, E.; Balnytė, I.; Valančiūtė, A.; Alonso, M.M.; Stakišaitis, D.
Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy. Biomedicines 2022, 10, 968.
https://doi.org/10.3390/biomedicines10050968
AMA Style
Damanskienė E, Balnytė I, Valančiūtė A, Alonso MM, Stakišaitis D.
Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy. Biomedicines. 2022; 10(5):968.
https://doi.org/10.3390/biomedicines10050968
Chicago/Turabian Style
Damanskienė, Eligija, Ingrida Balnytė, Angelija Valančiūtė, Marta Marija Alonso, and Donatas Stakišaitis.
2022. "Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy" Biomedicines 10, no. 5: 968.
https://doi.org/10.3390/biomedicines10050968
APA Style
Damanskienė, E., Balnytė, I., Valančiūtė, A., Alonso, M. M., & Stakišaitis, D.
(2022). Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy. Biomedicines, 10(5), 968.
https://doi.org/10.3390/biomedicines10050968
